FEBELFARMA
ActiveSummary
FEBELFARMA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.0m and a net result of €45,753. Equity is growing by about 5% per year across the filed financial years. Its solvency ranks better than 95% of 3,821 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
16-07
Gazette deed
Resignation: BV ALEXO (bestuurder)Permanent representatives: Olivier Delaere, Koen Straetmans and 2 others · Appointments: BV KST Pharma (director) and BV ARISTO (voorzitter van het bestuursorgaan)11 facts ▸
- General meeting, 18-05-2026
- Director resignation, BV ALEXO ((gedelegeerd) bestuurder)
- Permanent representative, Olivier Delaere
- Director appointment, BV KST Pharma (director)
- Permanent representative, Koen Straetmans
- Board meeting, 18-05-2026
- Director appointment, BV ARISTO (voorzitter van het bestuursorgaan)
- Permanent representative, Frank Coene
- Director appointment, BV KST Pharma (managing director)
- Other provision, “alle zaken die verband houden met de uitoefening van zijn mandaat”, elected domicile (deed in Dutch)
- Permanent representative, Eric Van Nueten
03-11
Gazette deed
Reappointment: Moore Audit BV (statutory auditor)Permanent representatives: Koen Van Eupen and Pieterjan Boeykens4 facts ▸
- General meeting, 16-04-2025
- Auditor reappointment, Moore Audit BV (statutory auditor)
- Permanent representative, Koen Van Eupen
- Permanent representative, Pieterjan Boeykens
30-10
Gazette deed
Appointments: Alexo, Aristo and Van Nueten Eric Flor AndréPermanent representatives: Olivier Delaere and Frank Coene · Reappointments: Alexo (managing director) and Aristo (chair of the board)9 facts ▸
- Board meeting, 12-09-2024
- Director appointment, Alexo (director (not named in the articles))
- Director appointment, Aristo (director (not named in the articles))
- Director appointment, Van Nueten Eric Flor André (director (not named in the articles))
- Permanent representative, Olivier Delaere
- Permanent representative, Frank Coene
- Director reappointment, Alexo (managing director)
- Director reappointment, Aristo (chair of the board)
- Director in office, Eveline Van den Abeele (director)
Show earlier events
About the unread acts
Of the 13 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.